SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001125345-22-000092
Filing Date
2022-10-17
Accepted
2022-10-17 16:22:57
Documents
15
Period of Report
2022-10-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20221017.htm   iXBRL 8-K 43131
2 EX-99.1 exhibit991gilead-macrogeni.htm EX-99.1 22559
6 image_0a.jpg GRAPHIC 10593
7 image_1a.jpg GRAPHIC 12439
  Complete submission text file 0001125345-22-000092.txt   241873

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20221017.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20221017_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20221017_pre.xml EX-101.PRE 12706
9 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20221017_htm.xml XML 10832
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 221313952
SIC: 2834 Pharmaceutical Preparations